• Michael Burd posted an update in the group Group logo of Research and DevelopmentResearch and Development 2 months, 1 week ago

    Nintedanib and Perfenidone COMBINED therapy.
    As these two drugs attack IPF in different ways there is consensus that taking both will produce better results than monotherapy. I would love to hear from anyone who has any recent testing information.

©[current-year] KLEO Template a premium and multipurpose theme from Seventh Queen